Hebrew University PhD student Maxim Mogilevsky and Prof. Rotem Karni in the Institute for Medical Research-Israel Canada lab. Photo by Polina Denichenko courtesy of Hebrew University

In November, Israeli scientists announced that they had discovered a promising new treatment for glioblastoma, a serious and incurable brain cancer which usually kills patients in 11-20 months from diagnosis. The researchers, from Hebrew University of Jerusalem, have designed a molecule that inhibits glioblastoma tumor growth by regulating the proteins it produces. As a result, cancerous tumors decrease or die. Tested in lab animals, the patent for the technology has now been granted in the US and Europe, and the long road to bringing the treatment to market has now begun.